fbpx
Qarbs: Accurate results for estimating carbohydrates

Qarbs: Accurate results for estimating carbohydrates

Qarbs: Accurate results for estimating carbohydrates

Estimating carbohydrates as supreme discipline for people living with diabetes is still depending on gut feelings and experiences. For self-prepared foods it’s most of the time a cakewalk but it becomes more complicated for unknown food items or at friend’s places. The same amount of pasta looks completely different on a small plate than on a bigger plate. To eliminate this source of error our target is offering a reliable digital solution that provides accurate results for an enhanced insulin dosage.

Several neural networks have been developed, trained and tested to be able providing an app that fulfills the needs of its users. Based on a set of pictures taken from the meal in front of you, a 3D model is developed and with this the app defines the volume of a single food item. A curated food database allows the app to define the amount of carbohydrate contented in the food item.

Realizing such a valuable app needs specialists from different areas such as nutrition, computer vision, design, software engineering and regulatory who work closely together. The dedicated team is keen on providing to people living with diabetes a certified medical device that does the carbohydrate counting for them.

Project team: Myriam Tinner (Product Manager, DCB), Melanie Stoll (Nutrition Specialist, DCB), Egemen Vardar&Tobias Maurer (Projektleiter, comerge AG), Andreas Pedroni (Quality Manager, comerge AG), Manuela Miksa&Rafal Wòjcik (UI/UX Designer, comerge AG)

Funding: DCB

App interface for meal scanning

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

The FibreGum study – Changing the course of obesity

The FibreGum study – Changing the course of obesity

The FibreGum study – Changing the course of obesity

The goal of our study is to increase weight reduction in obese children and adolescents by stimulating the gut microbiome with a chewing-gum containing dietary fibres as an adjunct treatment to standard adiposity therapy.

Non-invasive and low-threshold treatments are needed to combat childhood obesity

Around one in six children in Switzerland is affected by overweight or obesity and the prevalence continues to rise. This increase in obesity and its associated comorbidities represents a huge socio-economic burden, as it leads to increased morbidity and mortality. Obesity is not only a chronic disease in itself, but also a major risk factor for the development of the world’s leading causes of poor health and early death; namely cardiovascular disease, various cancers, diabetes and osteoarthritis.

Preventing obesity in children and adolescents offers a unique opportunity to prevent the path to an unhealthy adult life. A low-threshold offer could be the key to success. For this reason, we have developed a chewing gum enriched with dietary fibre, the “FibreGum”, in cooperation with Delica AG. The aim of the FibreGum is to improve microbial diversity and promote beneficial metabolites while reducing snacking. To investigate the efficacy of this chewing gum, we are conducting a randomised placebo-controlled clinical trial with a cohort of 105 obese children and adolescents. Obese children and adolescents (age 10-16 years, >97th percentile) who would like to participate in the FibreGum study are welcome to ask their family doctor for a referral to the Adipositassprechstunde at the Kinderklinik Bern (http://www.kinderklinik.insel.ch/de/unser-angebot/adipositas/). All participants in the FibreGum study must attend the Adipositassprechstunde.

Project team: Prof. Dr. Maria Luisa Balmer, Inselspital (University Hospital of Bern) and University of Bern (leading the project); Dr. Christoph Saner, Children’s hospital, Inselspital (University Hospital of Bern); Dr. Marco Janner, Children’s hospital, Inselspital (University Hospital of Bern); Prof. Dominik Meinel, University of Applied Sciences and Arts Northwestern Switzerland; Dr. Alexandra Stähli, Zahnmedizinische Kliniken Bern (University of Bern); Valentina Huwiler, Inselspital (University Hospital of Bern) and University of Basel; Marie-Aline Gerard, Diabetes Center Berne

Project funding: Diabetes Center Berne (research project), Von Tobel Stiftung (research project), Walter Fuchs Stiftung (research project), Swiss National Science Foundation

Prof. Dr. Maria Luisa Balmer is the head of the project.

More recent projects

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland